 ROCKVILLE, Md.--BUSINESS WIRE--GlycoMimetics, Inc. Nasdaq: GLYC today announced that three abstracts including data from the Companys clinical and research portfolio have been accepted for oral presentations and two abstracts have been accepted for poster presentations at the 62nd American Society of Hematology ASH Annual Meeting and Exposition, to be held virtually December 5-8, 2020. Of particular note are primary and key secondary endpoint data from additional analysis of the Phase 3 